CORCEPT THERAPEUTICS INC — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-01-04

Reporting Person: WILSON JAMES N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-04	Common stock	M	1188	$1.51	Acquired	1579584	Indirect
2016-01-06	Common stock	S	1188	$4.9031	Disposed	1578396	Indirect
2015-12-23	Common stock	G	7000	$0.00	Disposed	1571396	Indirect
2016-01-06	Common stock	S	0	$0.00	Disposed	901067	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Stock option	$1.51	M	1188	Disposed	2017-05-18	Common stock (1188)	Direct

Footnotes

F1: Represents the weighted average sale price for the entire number of shares sold.

F2: Shares distributed to family members of the Reporting Person.

F3: Not applicable as the line item has been included only to show all other indirect holdings of the Reporting Person.

F4: Fully exerciseable.